GZMB and urinary bladder cancer: A dose dependence response curve indicated that Sweet-P significantly (p < 0.05) decreased GRβ mRNA expression in the T24 human bladder cancer at 1.0 nM, 10 nM, 50 nM, and 100 nM (Figure 7B).